Lumea Lumea is the only comprehensive digital pathology solution that starts and ends with the patient. Our platform was made by pathologists for pathologists.

Lumea has the only digital pathology system that is built for clinics, labs, and pathologists to be on one comprehensive platform. We are the one company that actually makes going digital simple. What makes us so great? With us you can improve the quality of your practice, reduce costs, scale your business, and enjoy better and easier communication between clinics, labs, and pathology. You don't need 4 computer monitors to use our digital pathology. You only need one - and it can be an iPad. Order genetic tests with the click of a button, have instantaneous access to second opinions and consults, enjoy improved work location flexibility, be amazed by our artificial intelligence-powered automatic grossing, and annotate digitally and watch as our deep learning software auto populates a report for you. But even more importantly. The clinic has it's EMR, the lab has it's LIS, radiology has it's RIS, genetic testing companies have their own system, pathologists have their slide viewer and in the end most of these users interface using fax machines and PDFs. Lumea breaks that siloed tradition by uniting everyone on the same platform starting in the clinic. With us you will see improved chain of custody, easier and better communication between clinics, labs, and pathology, and your specimen slides will even be better by using our technology. Have we got your attention yet? Visit our website to learn more and request a demo to see what we can do to make the best digital pathology system in the world a reality for you!

We are excited to announce that Clarissa Baird has joined the Lumea team as our newest Lab Assistant!Clarissa is a fanta...
09/14/2026

We are excited to announce that Clarissa Baird has joined the Lumea team as our newest Lab Assistant!

Clarissa is a fantastic addition to our laboratory operations, and we are thrilled to have her stepping into this role to help drive our mission forward. Please join us in giving Clarissa a warm welcome to the team.

We are thrilled to welcome Zach Cygan to the Lumea team as our new Client Success Manager!Zach brings a highly versatile...
09/10/2026

We are thrilled to welcome Zach Cygan to the Lumea team as our new Client Success Manager!

Zach brings a highly versatile background to the table. With a degree in Psychology and a minor in Business Administration from CSUF, he understands people and business operations. We are excited to see him bring that diverse expertise to our clients here at Lumea.

Welcome aboard, Zach!

We are so excited to announce that our BxBoard® has been named a top innovation in the MedTech Devices & Diagnostics cat...
09/08/2026

We are so excited to announce that our BxBoard® has been named a top innovation in the MedTech Devices & Diagnostics category at the 2026 Utah Innovation Awards!

A massive thank you to Utah Business and Nucleus for this honor, and to our dedicated team for pushing the boundaries of digital pathology and precision oncology.

Read more: https://lumeadigital.com/2026-utah-innovation-award-winner/

Big news: Alpine Path is now integrated into Lumea's digital pathology workflow.We partnered with TreatmentGPS to bring ...
09/01/2026

Big news: Alpine Path is now integrated into Lumea's digital pathology workflow.

We partnered with TreatmentGPS to bring guideline-based clinical decision support directly into the report. So when pathology findings come back, providers don't have to manually cross-reference NCCP guidelines to know what to do next.

Alpine Path generates a structured clinical summary alongside the pathologist's report: NCCN-based risk stratification, ancillary testing considerations, and treatment guidance. It also produces a plain-language version for the patient. Both in one place, no extra logins.

This is the kind of integration connects the diagnosis to a clear next step, not just delivering a result.

Learn more: https://lumeadigital.com/treatmentgps-launches-alpine-path-integration-in-lumeas-platform-bringing-ai-powered-treatment-guidance-directly-into-pathology-reports/

Up to 1 in 5 FNA specimens comes back QNS. For patients, that's another procedure. For labs, it's another line in the qu...
08/25/2026

Up to 1 in 5 FNA specimens comes back QNS. For patients, that's another procedure. For labs, it's another line in the quality report. For trial sponsors, it may be a closed door.

This week at the Digital Diagnostic Summit, Lumea's R&D team will have a booth where you can see what we're doing about it, including an early look at CytoPod and CytoVac, our unique filtration approach to cell block prep that's changing what "paucicellular" actually means for diagnostic yield.

Come find us, ask hard questions, and tell us what you need. We're here for the collaboration.

DDx Summit | August 27–29 | St. Regis Deer Valley

Read more here: https://lumeadigital.com/the-hidden-cost-of-quantity-not-sufficient-qns-in-cytology/

QNS rates in metastatic prostate cancer samples can reach 23%. That single failure point delays diagnosis, adds cost, an...
08/14/2026

QNS rates in metastatic prostate cancer samples can reach 23%. That single failure point delays diagnosis, adds cost, and forces patients back through repeat biopsies.

In a comparative analysis looking at how specimen collection method affects this rate directly, BxBoard-collected specimens saw a 0.59% combined QNS/RNA degradation rate, versus 1.27% for traditional formalin bottles. That's 2.1x fewer cancellations.

Read the full case study by Heather Hansen, Lumea's R&D Research Manager and Pathologists' Assistant here: https://lumeadigital.com/improving-specimen-integrity-with-the-bxboard/

Please join us in welcoming Jayden Bateman to Lumea as a Manufacturing Technician!Jayden brings a hands-on, builder's mi...
08/12/2026

Please join us in welcoming Jayden Bateman to Lumea as a Manufacturing Technician!

Jayden brings a hands-on, builder's mindset to the role, with a background in IT, mechanical engineering, and CAD-based design work. We're excited to have someone with such a strong drive to learn and build joining the team!

08/11/2026

We couldn't be prouder of our team right now. Lumea has ranked on the Inc. 5000 list for the second consecutive year, moving up more than 800 spots to No. 1,641 among America's fastest-growing private companies.

“Climbing to No. 1,641 from No. 2,468 last year is a direct reflection of the momentum behind Lumea’s mission to make quality cancer diagnostics accessible everywhere,” said James Thackeray, Lumea CEO. “This recognition speaks to the dedication of our entire team and our continued investment in efficient, affordable digital pathology, and we’re proud to keep building the future of cancer diagnostics.”

07/30/2026

Toggle tax is real. Every time a pathologist jumps from slide viewer to reporting screen to re-key what they just dictated, that's lost time and an added error risk.

Independent 2026 industry research by BestLabTech recognized Lumea + elea for solving this differently: an AI-native ecosystem where voice-dictated grossing notes are automatically drafted into the report as the pathologist works.

It's not a plug-in. It's the workflow.

Grateful for this recognition and for the partnership behind it.

Address

2889 Ashton Boulevard, #300
Lehi, UT
84043

Opening Hours

Monday 6am - 5pm
Tuesday 6am - 5pm
Wednesday 6am - 5pm
Thursday 6am - 5pm
Friday 6am - 5pm

Telephone

+18449603658

Alerts

Be the first to know and let us send you an email when Lumea posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lumea:

Shortcuts

Share